688331 (688331) News
Track canonical SquawkNews coverage tagged to 688331, 688331. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
US drugmakers turn to China for licensing deals
Merck NYSE:MRK on Monday agreed to pay Chinese biotech SciBrunch Therapeutics $400 million upfront for global rights to an experimental cancer drug, making it the latest US drugmaker to license China-developed medicines.
GEOPOLITICS | Sep 28, 2026, 02:31 PM UTC
L
RemeGen enters SPDB Wealth Management product agreement No. 11
RemeGen Co., Ltd. has entered into a SPDB Wealth Management product agreement No. 11.
EQUITY | Sep 02, 2026, 03:32 PM UTC